1. Home
  2. CVRX vs TOYO Comparison

CVRX vs TOYO Comparison

Compare CVRX & TOYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • TOYO
  • Stock Information
  • Founded
  • CVRX 2000
  • TOYO 2022
  • Country
  • CVRX United States
  • TOYO Japan
  • Employees
  • CVRX N/A
  • TOYO N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TOYO
  • Sector
  • CVRX Health Care
  • TOYO
  • Exchange
  • CVRX Nasdaq
  • TOYO NYSE
  • Market Cap
  • CVRX 174.4M
  • TOYO 153.8M
  • IPO Year
  • CVRX 2021
  • TOYO N/A
  • Fundamental
  • Price
  • CVRX $5.89
  • TOYO $3.73
  • Analyst Decision
  • CVRX Buy
  • TOYO
  • Analyst Count
  • CVRX 7
  • TOYO 0
  • Target Price
  • CVRX $14.50
  • TOYO N/A
  • AVG Volume (30 Days)
  • CVRX 232.7K
  • TOYO 17.6K
  • Earning Date
  • CVRX 07-28-2025
  • TOYO 05-15-2025
  • Dividend Yield
  • CVRX N/A
  • TOYO N/A
  • EPS Growth
  • CVRX N/A
  • TOYO 350.49
  • EPS
  • CVRX N/A
  • TOYO 1.09
  • Revenue
  • CVRX $52,870,000.00
  • TOYO $176,957,128.00
  • Revenue This Year
  • CVRX $11.53
  • TOYO N/A
  • Revenue Next Year
  • CVRX $18.61
  • TOYO N/A
  • P/E Ratio
  • CVRX N/A
  • TOYO $3.41
  • Revenue Growth
  • CVRX 25.62
  • TOYO 183.69
  • 52 Week Low
  • CVRX $4.30
  • TOYO $1.36
  • 52 Week High
  • CVRX $18.55
  • TOYO $8.34
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 41.15
  • TOYO N/A
  • Support Level
  • CVRX $5.54
  • TOYO N/A
  • Resistance Level
  • CVRX $5.96
  • TOYO N/A
  • Average True Range (ATR)
  • CVRX 0.40
  • TOYO 0.00
  • MACD
  • CVRX -0.03
  • TOYO 0.00
  • Stochastic Oscillator
  • CVRX 21.99
  • TOYO 0.00

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About TOYO TOYO CO LTD

Toyo Co Ltd along with its subsidiaries, is engaged in research and development, production, and sales of solar cells. Geographically, the company generates revenue from Asia and the USA, out of which the majority of revenue is generated from Asia.

Share on Social Networks: